Literature DB >> 4277669

Structural changes accompanying enzymatic activation of human Hageman factor.

S D Revak, C G Cochrane, A R Johnston, T E Hugli.   

Abstract

The structure of Hageman factor, isolated from human plasma, was analyzed before and after enzymatic activation. The purified molecule is a single polypeptide chain of 80,000 molecular weight (mol wt) sedimenting at 4.5S. An amino acid analysis has been performed. The concentration of Hageman factor in normal human plasma was found to be 29 mug/ml with variation between individuals ranging from 15 to 47 mug/ml. Treatment of the molecule with kallikrein, plasmin, or trypsin resulted in cleavage at two primary sites, yielding fragments of 52,000, 40,000, and 28,000 mol wt. No further changes occurred in the fragments with subsequent reduction. Prekallikrein-activating ability was associated exclusively with the 28,000 moiety.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4277669      PMCID: PMC301595          DOI: 10.1172/JCI107799

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  The purification of activated Hageman factor (activated factor XII).

Authors:  O D RATNOFF; E W DAVIE
Journal:  Biochemistry       Date:  1962-11       Impact factor: 3.162

3.  Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition.

Authors:  O D RATNOFF; J M ROSENBLUM
Journal:  Am J Med       Date:  1958-08       Impact factor: 4.965

4.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

5.  Immunologic demonstration of a deficiency of Hageman factor-like material in Hageman trait.

Authors:  M M Smink; T M Daniel; O D Ratnoff; A B Stavitsky
Journal:  J Lab Clin Med       Date:  1967-05

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  A pre-albumin activator of prekallikrein.

Authors:  A P Kaplan; K F Austen
Journal:  J Immunol       Date:  1970-10       Impact factor: 5.422

8.  Plasma prekallikrein: isolation, characterization, and mechanism of activation.

Authors:  K D Wuepper; C G Cochrane
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

9.  A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin.

Authors:  A P Kaplan; K F Austen
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307

10.  The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator.

Authors:  A P Kaplan; K F Austen
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  19 in total

1.  The search for a new model structure of beta-factor XIIa.

Authors:  E S Henriques; W B Floriano; N Reuter; A Melo; D Brown; J A Gomes; B Maigret; M A Nascimento; M J Ramos
Journal:  J Comput Aided Mol Des       Date:  2001-04       Impact factor: 3.686

2.  Partial purification and characterization of contact activation cofactor.

Authors:  S Schiffman; P Lee
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

3.  Inhibition of prekallikrein activation in human plasma by components of bovine plasma.

Authors:  K M Weerasinghe; E P Kirby
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

Review 4.  FXII.

Authors:  G Fuhrer; M J Gallimore; W Heller; H E Hoffmeister
Journal:  Blut       Date:  1990-11

Review 5.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

6.  The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule.

Authors:  S D Revak; C G Cochrane
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

7.  Amidolytic properties of single-chain activated Hageman factor.

Authors:  O D Ratnoff; H Saito
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

8.  Surface activation of factor XII (Hageman factor)--critical role of high molecular weight kininogen and another potentiator).

Authors:  J Y Chan; C E Burrowes; H Z Movat
Journal:  Agents Actions       Date:  1978-01

9.  Rabbit prekallikrein. Purification, biochemical characterization, and mechanism of activation.

Authors:  R J Ulevitch; C G Cochrane; A R Johnston
Journal:  Inflammation       Date:  1980-03       Impact factor: 4.092

10.  Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.

Authors:  A de Agostini; H R Lijnen; R A Pixley; R W Colman; M Schapira
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.